BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 25, 2008
View Archived Issues
Alpharma Rethinks King's Bid, Agrees to be Acquired for $1.6B
Two months after urging shareholders to reject a $37-per-share offer from King Pharmaceuticals Inc., Alpharma Inc. changed its mind and agreed to the merger, which values the specialty pharma firm at about $1.6 billion. (BioWorld Today)
Read More
J&J Seeks to Acquire Omrix in $438M Cash Tender Offer
Read More
Host Cell Components Promising Broad-Spectrum Antiviral Targets
Read More
NewCo News: Compellis Does Obesity Drug Development by the Nose
Read More
Another Depomed Deal: $68M Delivery License with Covidien
Read More
Naproxcinod Meets Endpoints in Third Phase III Arthritis Trial
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Financings Roundup
Read More